Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$162.55 USD

162.55
1,075,255

+3.61 (2.27%)

Updated Aug 21, 2026 04:00 PM ET

After-Market: $161.73 -0.82 (-0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 247)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up

by Zacks Equity Research

SYK's second-quarter results reflect strong segmental performance, along with a rise in operating margin.

Zacks Equity Research

BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down

by Zacks Equity Research

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

Zacks Equity Research

DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise

by Zacks Equity Research

DXCM beats on Q2 earnings and raises 2025 sales guidance, but shares dip as margin pressure dampens investor enthusiasm.

Zacks Equity Research

ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down

by Zacks Equity Research

Align Technology tumbles 34.2% after Q2 earnings and revenues miss estimates as Clear Aligner sales drop and margins tighten further.

Zacks Equity Research

Align Technology (ALGN) Reports Q2 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Align Technology (ALGN) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Align Technology (ALGN) delivered earnings and revenue surprises of -3.11% and -4.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View

by Zacks Equity Research

Revvity's second-quarter results showcase strong growth in its Diagnostics business, along with recovery in Life Sciences segmental sales.

Zacks Equity Research

WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit

by Zacks Equity Research

West Pharmaceutical's second-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.

Zacks Equity Research

Can Robust Invisalign Momentum Drive Align Technology's Q2 Earnings?

by Zacks Equity Research

ALGN is likely to have delivered robust Q2 2025 performance as Invisalign traction and iTero upgrades gained steam across global markets.

Zacks Equity Research

Align Technology (ALGN) Recently Broke Out Above the 200-Day Moving Average

by Zacks Equity Research

When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?